Hakutulokset - Issa, Nicolas C

Sequencing and Resolution of Amplified Herpes Simplex Virus DNA with Intermediate Melting Curves as Genotype 1 or 2 by LightCycler PCR Assay Tekijä Issa, Nicolas C., Espy, Mark J., Uhl, James R., Smith, Thomas F.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Pneumocystis jirovecii pneumonia and institutional prophylaxis practices in CLL patients treated with BTK inhibitors Tekijä Ryan, Christine E., Cheng, Matthew P., Issa, Nicolas C., Brown, Jennifer R., Davids, Matthew S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Candida albicans Cervical Lymphadenitis in Patients Who Have Acute Myeloid Leukemia Tekijä Alsan, Marcella M., Issa, Nicolas C., Hammond, Sarah P., Milner, Danny A., DeAngelo, Daniel J., Baden, Lindsey R.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Absence of Replication of Porcine Endogenous Retrovirus and Porcine Lymphotropic Herpesvirus Type 1 with Prolonged Pig Cell Microchimerism after Pig-to-Baboon Xenotransplantation Tekijä Issa, Nicolas C., Wilkinson, Robert A., Griesemer, Adam, Cooper, David K. C., Yamada, Kazuhiko, Sachs, David H., Fishman, Jay A.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

1557. Acyclovir-Resistant (ACV-R) Herpes Simplex Virus (HSV) Disease in Patients with Hematologic Malignancies (HM) and Hematopoietic-Cell Transplant (HCT) Recipients Tekijä Pandit, Alisha, Cheng, Matthew P, Liakos, Alexis, Treister, Nathaniel, Baden, Lindsey R, Issa, Nicolas C, Marty, Francisco M, Hammond, Sarah P

Hae kokoteksti Hae kokoteksti

36. Safety and Reactogenicity of the Adjuvanted Recombinant Zoster Vaccine after Allogeneic Hematopoietic Stem Cell Transplantation Tekijä Baumrin, Emily, Izaguirre, Natalie E, Bausk, Bruce P, Feeley, Monica M, Bay, Camden P, Ho, Vincent T, Issa, Nicolas C, Baden, Lindsey R

Hae kokoteksti Hae kokoteksti

Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation Tekijä Baumrin, Emily, Izaguirre, Natalie E., Bausk, Bruce, Feeley, Monica M., Bay, Camden P., Yang, Qiheng, Ho, Vincent T., Baden, Lindsey R., Issa, Nicolas C.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell Transplant Tekijä Desjardins, Michaël, Mitre, Xhoi, Sherman, Amy C, Walsh, Stephen R, Cheng, Matthew P, Kanjilal, Sanjat, Ho, Vincent T, Baden, Lindsey R, Issa, Nicolas C

Hae kokoteksti Hae kokoteksti Hae kokoteksti

100. Safety Analysis of Live-Attenuated Measles, Mumps, Rubella Vaccine Among Hematopoietic Cell Transplant Recipients Vaccinated Within Two Years of Transplant Tekijä Mitre, Xhoi, Feeley, Monica, Sherman, Amy C, Walsh, Stephen R, Cheng, Matthew, Kanjilal, Sanjat, Ho, Vincent T, Baden, Lindsey R, Issa, Nicolas C, Desjardins, Michaël

Hae kokoteksti Hae kokoteksti

Serum Galactomannan and (1→3)-β-d-Glucan Assays for Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia Tekijä Issa, Nicolas C., Koo, Sophia, Lynch, Robert C., Gay, Charline, Hammond, Sarah P., Baden, Lindsey R., Ghobrial, Irene M., Finkelman, Malcolm A., Marty, Francisco M.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation Tekijä Cheng, Matthew P., Pandit, Alisha, Antin, Joseph H., Walsh, Stephen R., Huynh, Daisy, Ghobrial, Irene M., Baden, Lindsey R., Marty, Francisco M., Issa, Nicolas C.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19 Tekijä Finberg, Robert W, Ashraf, Madiha, Julg, Boris, Ayoade, Folusakin, Marathe, Jai G, Issa, Nicolas C, Wang, Jennifer P, Jaijakul, Siraya, Baden, Lindsey R, Epstein, Carol

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Green Herring Syndrome: Bacterial Infection in Patients With Mucormycosis Cavitary Lung Disease Tekijä Peixoto, Driele, Hammond, Sarah P., Issa, Nicolas C., Madan, Rachna, Gill, Ritu R., Milner, Danny A., Colson, Yolonda L., Koo, Sophia, Baden, Lindsey R., Marty, Francisco M.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

1130. Low Risk of Pneumocystis jiroveci Pneumonia in Patients With Waldenstrom’s Macroglobulinemia on Ibrutinib Tekijä Kusztos, Amanda E, Cheng, Matthew P, Gustine, Joshua N, Dubeau, Toni E, Woolley, Ann E, Hammond, Sarah P, Baden, Lindsey R, Castillo, Jorge J, Issa, Nicolas C

Hae kokoteksti Hae kokoteksti

Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity Tekijä Sherman, Amy C, Desjardins, Michaël, Cheng, Chi-An, Bausk, Bruce, Izaguirre, Natalie, Zhou, Guohai, Krauss, Jonathan, Tolan, Nicole, Walt, David R, Soiffer, Robert, Ho, Vincent T, Issa, Nicolas C, Baden, Lindsey R

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Seroprotective Titers against 2009 H1N1 Influenza A Virus after Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Recipients Tekijä Issa, Nicolas C., Marty, Francisco M., Gagne, Lisa S., Koo, Sophia, Verrill, Kelly A., Alyea, Edwin P., Cutler, Corey S., Koreth, John, Armand, Philippe, Ho, Vincent T., Antin, Joseph H., Soiffer, Robert J., Baden, Lindsey R.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

586. Immunogenicity of COVID-19 mRNA Vaccines in Patients with Lymphoid Malignancies Tekijä Izaguirre, Natalie E, Sherman, Amy C, Crombie, Jennifer, Desjardins, Michaël, Cheng, Chi-An, Gilboa, Tal, Powell, Megan, Bausk, Bruce P, Abasciano, Noah, Baker, Peter, McDonough, Mikaela, Armand, Philippe, Walt, David, Issa, Nicolas C, Baden, Lindsey R

Hae kokoteksti Hae kokoteksti

1060. Pritelivir in Immunocompromised Patients with Mucocutaneous Acyclovir-Resistant Herpes Simplex Virus-Infections – First Case Series Tekijä Albrecht, Kim WorkowskiJoerg, Avery, Robin K, Avery, Robin K, Chandrasekar, Pranatharthi, Chemaly, Roy F, Issa, Nicolas C, Kotton, Camille, Kotton, Camille, Kumar, Princy N, Mayur, Ramesh, Ramgopal, Moti, Schiffer, Joshua, Wald, Anna, Ison, Michael G

Hae kokoteksti Hae kokoteksti

Poxvirus Vectored CMV Vaccine to Prevent CMV Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial Tekijä Aldoss, Ibrahim, La Rosa, Corinna, Baden, Lindsey R., Longmate, Jeffrey, Ariza-Heredia, Ella J., Rida, Wasima N., Lingaraju, Chetan Raj, Zhou, Qiao, Martinez, Joy, Kaltcheva, Teodora, Dagis, Andy, Hardwick, Nicola, Issa, Nicolas C., Farol, Len, Nademanee, Auayporn, Al Malki, Monzr M., Forman, Stephen, Nakamura, Ryotaro, Diamond, Don J.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

25. Immunogenicity and Reactogenicity of COVID-19 mRNA Vaccines in Allogeneic Stem Cell Transplant Recipients Tekijä Bausk, Bruce P, Sherman, Amy C, Desjardins, Michaël, Izaguirre, Natalie E, Cheng, Chi-An, Powell, Megan, Senussi, Yasmeen, Gilboa, Tal, Krauss, Jonathan H, Dirr, Bonnie, Power, Elyssa, Joyce, Amy, Stewart, Lisa, Ometoruwa, Omolola, Novack, Lewis A, Evans, Bethany, Woods, Tenaizus, Tong, Alexandra, Walt, David, Soiffer, Robert, Ho, Vincent T, Issa, Nicolas C, Baden, Lindsey R

Hae kokoteksti Hae kokoteksti